Newron Pharmaceuticals S.p.A. pauses enrollment in US ENIGMA-TRS 2 study; FDA hold on US enrollment, ongoing safety review
Newron Pharmaceuticals S.p.A. pauses enrollment in US ENIGMA-TRS 2 study; FDA hold on US enrollment, ongoing safety review Newron reports a pause in enrollment of new study participants in US centers of ENIGMA-TRS 2 study Newron reports a pause in enrollment of new study participants in US centers of ENIGMA-TRS 2 study Ad hoc announcement pursuant to Art. 53 LR Newronreportsa pause inenrollment of new study participants in US centers of ENIGMA-TRS 2 study ...